The Effects of a Sublingual Sprayable Microemulsion of Vitamin D on Inflammatory Markers in COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

March 31, 2021

Study Completion Date

June 9, 2021

Conditions
COVID-19Vitamin D Deficiency
Interventions
DIETARY_SUPPLEMENT

Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion

This is a prospective, randomized, double blind, and controlled clinical study to investigate the impact of the high dose vitamin D supplementation on laboratory markers of systemic inflammation such as CRP, ferritin and IL-6 in hospitalized patients with COVID-19. Patients included in the study will be randomized into two groups and receive a placebo (as a control group) or cholecalciferol administered sublingually for 5 day

Trial Locations (1)

LV-1002

Pauls Stradins Clinical Univeristy Hospital, Riga

All Listed Sponsors
lead

Pauls Stradins Clinical University Hospital

OTHER

NCT05502068 - The Effects of a Sublingual Sprayable Microemulsion of Vitamin D on Inflammatory Markers in COVID-19 Patients | Biotech Hunter | Biotech Hunter